Sera from 46 chimpanzees with spongiform encephalopathy (18 kuru, 28 Creutzfeldt-Jakob disease) and sera from 12 sheep with natural scrapie were tested for reactivity with immunoblots of neurofilament preparations obtained from mouse brain. The sera from the chimpanzees reacted mainly with the 200-and 150-kDa proteins of the neurofflament triplet and less frequently with the 70-kDa component of the triplet and with a 62-kDa neurofilament-associated protein. In contrast, the sera of sheep with natural scrapie reacted exclusively against the 62-kDa protein. (2) have shown previously that the serum of one chimpanzee with Creutzfeldt-Jakob disease reacted mainly with the 200-kDa, and less strongly with the 150-kDa neurofilament protein.
In this work, the specificity of the antineurofilament autoantibody in chimpanzees with experimental kuru and Creutzfeldt-Jakob disease and in sheep with natural scrapie (1) was investigated by immunoblotting studies with sera from 46 chimpanzees with spongiform encephalopathy (18 kuru, 28 Creutzfeldt-Jakob disease), 16 chimpanzees inoculated with human material from patients with other neurologic diseases, 12 sheep with natural scrapie, and 8 normal sheep. The sera of chimpanzees with spongiform encephalopathy reacted mainly with the 200-and 150-kDa proteins of the neurofilament triplet, whereas the sera of sheep with natural scrapie reacted exclusively with a 62-kDa neurofilament-associated protein. Bahmanyar et al. (2) have shown previously that the serum of one chimpanzee with Creutzfeldt-Jakob disease reacted mainly with the 200-kDa, and less strongly with the 150-kDa neurofilament protein.
MATERIALS AND METHODS
Sera. Paired pre-and post-inoculation sera from 62 chimpanzees were examined for reactivity with immunoblots of neurofilament-enriched preparations from mouse brain. The chimpanzees comprised 28 that had been inoculated with suspensions of Creutzfeldt-Jakob disease-infected human and animal brain tissues, 18 that had been inoculated with suspensions of kuru-infected human and animal brain tissues, and 16 that had been inoculated with suspensions of brain tissues from human patients with other central nervous system diseases (4 patients with amyotrophic lateral sclerosis, 2 patients with parkinsonism-dementia, 2 patients with Alzheimer disease, 1 patient with subacute sclerosing panencephalitis, 1 patient with striatal degeneration, 1 patient with Schilder disease, and 2 patients with progressive supranuclear palsy). Also examined were sera from 12 sheep with natural scrapie and from 8 normal sheep.
Neurofilament Preparation. The method for obtaining preparations from mouse brains enriched for the 200-, 150-, and 70-kDa neurofilament proteins and the 62-kDa neurofilament-associated protein has been described (3, 4). Briefly, whole mouse brains were homogenized at 4°C in phosphatebuffered saline containing 0.6 M KCI and 0.5% Triton X-100 (wt/vol), centrifuged at 16,319 x g in a Sorval GSA rotor, for 10 min, resuspended in the same buffer without Triton X-100, and centrifuged again to obtain a pellet enriched for neurofilament protein.
Immunoblotting. The immunoblotting technique used has been described (4, 5) . Briefly, the proteins in the mouse neurofilament-enriched preparation were separated by NaDodSO4/PAGE (6) in slab gels and then electrophoretically transferred to nitrocellulose paper. The transferred proteins were incubated with chimpanzee or sheep sera followed by peroxidase-labeled goat anti-human or antisheep IgG. Immunoreactive bands were visualized with 4-chloro-1-napthol and hydrogen peroxide (7) . Specificity Studies. To establish specificity of the autoantibody reaction for neurofilament proteins, immunoblot reactivity obtained with chimpanzee sera was compared to those obtained with rabbit and mouse polyclonal antibodies (8) , with mouse monoclonal antibody (characterization to be described elsewhere), and with a human autoantibody (4) to neurofilament proteins. The appropriate proxidase-labeled goat anti-IgG was used as second antibody in these experiments.
To demonstrate species non-specificity of the autoantibody reactions, immunoblots carried out with mouse neurofilament-enriched preparations were compared to immunoblots with chimpanzee neurofilament-enriched preparations and with neurofilament preparations from bovine spinal cord.
RESULTS
The results summarized in Tables 1 and 2 show that chimpanzee sera reacted most frequently with the 200-and 150-kDa proteins and less frequently with the 70-and 62-kDa proteins. In contrast, the sera of sheep with natural scrapie 3894 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. reacted exclusively with the 62-kDa dalton neurofilamentassociated protein (Fig. 1) . The incidence of autoantibody to neurofilament proteins was higher in post-inoculation sera than in pre-inoculation sera from chimpanzees inoculated with kuru or CreutzfeldtJakob disease-infected material, but an increase in autoantibody inoculated with material from patients with other neurologic diseases.
The chimpanzee autoantibody reacted with the same proteins that were recognized by rabbit and mouse polyclonal antibodies, by mouse monoclonal antibody, and by a human autoantibody to neurofilament proteins (Fig. 2) . The autoantibody, in preinoculation sera when present, was directed against the same neurofilament proteins as the antibody in postinoculation sera (Fig. 3) . The chimpanzee autoantibody reacted not only with mouse neurofilament preparations but also with neurofilament preparations from chimpanzee brain and from bovine spinal cord, although reactivity with the corresponding proteins in the different species was not always obtained (Fig. 4) .
DISCUSSION
In a companion study (4), we showed that the human antineurofilament autoantibody in patients with kuru and Creutzfeldt-Jakob disease (9-12) is directed mainly against the 200-and 150-kDa proteins of the neurofilament triplet. The present study shows that the anti-neurofilament autoantibody previously reported in chimpanzees with experimental kuru and Creutzfeldt-Jakob disease (1) is also directed mainly against the same proteins, reaffirming the association between the anti-200-/150-kDa protein autoantibodies and these spongiform encephalopathies. We have previously speculated (4) that these autoantibodies may be directed against antigen(s) common to both the 200-/150-kDa proteins and the infectious "scrapie-associated fibrils" ofkuru and Creutzfeldt-Jakob disease (13, 14) . Gajdusek (15) (16) (17) has suggested that autoantibody-producing B-cell clones are activated as a result ofrelease ofneurofilament proteins after neurolysis due to a block in axonal transport of these proteins. We found that the anti-neurofilament autoantibody reported previously in sheep with natural scrapie (1) is not directed against the 200-and 150-kDa proteins but exclusively against a 62-kDa protein. This 62-kDa protein is not part of the neurofilament triplet but is probably associated with it: this protein disappears together with the triplet proteins after wallerian degeneration (18) . This difference in specificity of autoantibodies in kuru and Creutzfeldt-Jakob disease, on the one hand, and in sheep with natural scrapie, on the other, should be further investigated. 
